Jacqueline A. Pugh, MD

Articles by Jacqueline A. Pugh, MD

Adalimumab Persistence for Inflammatory Bowel Disease in Veteran and Insured Cohorts

ByShail M. Govani, MD, MSc,Rachel Lipson, MSc,Mohamed Noureldin, MBBS, MSc,Wyndy Wiitala, PhD,Peter D.R. Higgins, MD, PhD, MSc,Sameer D. Saini, MD, MSc,Jacqueline A. Pugh, MD,Dawn I. Velligan, PhD,Ryan W. Stidham, MD, MSc,Akbar K. Waljee, MD, MSc

Veterans with inflammatory bowel disease taking adalimumab appear to be more likely to remain on the drug 1 year after initiation than patients who are privately insured.

Latest Updated Articles



Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text